Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of scleral fibroblasts proliferation

Molecular Vision

Volumn 15, Issue , 2009, Pages 1277-1293

  Barathi, V A ^a   Weon, S R ^a   Beuerman, R W ^a,b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; B RAF KINASE; BROXURIDINE; CARBACHOL; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; FOCAL ADHESION KINASE 2; HIMBACINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE; PROTEIN KINASE; PROTEIN KINASE C; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FROZEN SECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; CARBACHOL; CELL PROLIFERATION; CHOLINERGIC AGONISTS; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, MUSCARINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCLERA; SIGNAL TRANSDUCTION;

EID: 67650667471     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Wu HM, Seet B, Yap EP, Saw SM, Lim TH, Chia KS. Does education explain ethnic differences in myopia prevalence? A population-based study of young adult males in Singapore. Optom Vis Sci 2001; 78:234-9.
2. Saw SM. A synopsis of the prevalence rates and environmental risk factors for myopia. Clin Exp Optom 2003; 86:289-94.
3. Saw SM. How blinding is pathological myopia? Br J Ophthalmol 2006; 90:525-6.
4. Shih YF, Hsiao CK, Chen CJ, Chang CW, Hung PT, Lin LL. An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression. Acta Ophthalmol Scand 2001; 79:233-6.
5. Saw SM, Gazzard G, Au Eong KG, Tan DT. Myopia: attempts to arrest progression. Br J Ophthalmol 2002; 86:1306-11.
6. Tan DT, Lam DS, Chua WH, Shu-Ping DF, Crockett RS, Asian Pirenzepine Study Group. One-year multicenter, doublemasked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology 2005; 112:84-91.
7. Leech EM, Cottriall CL, McBrien NA. Pirenzepine prevents form deprivation myopia in a dose dependent manner. Ophthalmic Physiol Opt 1995; 15:351-6.
8. Tigges M, Iuvone PM, Fernandes A, Sugrue MF, Mallorga PJ, Laties AM, Stone RA. Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys. Optom Vis Sci 1999; 76:397-407.
9. Duncan G, Collison DJ. Role of the non-neuronal cholinergic system in the eye: a review. Life Sci 2003; 72:2013-9.
10. Barathi VA, Boopathi VG, Yap EP, Beuerman RW. Two models of experimental myopia in the mouse. Vision Res 2008; 48:904-16.
11. Caulfield MP. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 1993; 58:319-79.
12. Wessler I, Kirkpatrick CJ, Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 1998; 77:59-79.
13. Wessler I, Kilbinger H, Bittinger F, Unger R, Kirkpatrick CJ. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci 2003; 72:2055-61.
14. McBrien NA, Cottriall CL, Annies R. Retinal acetylcholine content in normal and myopic eyes: a role in ocular growth control? Vis Neurosci 2001; 18:571-80.
15. Weon SR, Barathi VA, Beuerman RW. Muscarinic toxins from green mamba venom modulate the proliferative actions of muscarinic receptor subtypes (mAChRs) expressed in mouse and human scleral fibroblasts. Proceedings of the 2nd SERI-ARVO Meeting on Research in Vision and Ophthalmology; 2005 February 16-20; Singapore.
16. Fischer AJ, McKinnon LA, Nathanson NM, Stell WK. Identification and localization of muscarinic acetylcholine receptors in the ocular tissues of the chick. J Comp Neurol 1998; 392:273-84.
17. Lind GJ, Chew SJ, Marzani D, Wallman J. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci 1998; 39:2217-31. [PMID: 9804129]
18. Kanno H, Horikawa Y, Hodges RR, Zoukhri D, Shatos MA, Rios JD, Dartt DA. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Am J Physiol Cell Physiol 2003; 284:C988-98.
19. fak); a point of convergence in the action of neuropeptides, integrins and oncogenes. Cell 1992; 71:891-4.
20. Aoki Y, Isselbacher KJ, Pillai S. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre B lymphocytes and receptor ligated B cells. Proc Natl Acad Sci USA 1994; 91:10606-9.
21. August A, Gibson S, Kawakami Y, Kawakami T, Mills GB, Dupont B. CD28 is associated with an induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T cell line. Proc Natl Acad Sci USA 1994; 91:9347-51.
22. Chen JM, Aimes RT, Ward GR, Youngleib GL, Quigley JP. Isolation and characterisation of a 70kd metalloproteinase (gelatinase) that is elevated in Rous sarcoma virus transformed embryo fibroblasts. J Biol Chem 1991; 266:5113-21.
23. Collison DJ, Coleman RA, James RS, Carey J, Duncan G. Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques. Invest Ophthalmol Vis Sci 2000; 41:2633-41.
24. Gil DW, Krauss HA, Bogardus AM, WoldeMussie E. Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation. Invest Ophthalmol Vis Sci 1997; 38:1434-42.
25. Matthiesen S, Bahulayan A, Kempkens S, Haag S, Fuhrmann M, Stichnote C, Juergens UR, Racke K. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol 2006; 35:621-7.
26. Ryberg AT, Warfvinge G, Axelsson L, Soukup O, Gotrick B, Tobin G. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man. Arch Oral Biol 2008; 53:66-74.
27. Qu J, Zhou X, Xie R, Zhang L, Hu D, Li H, Lu F. The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists. Curr Eye Res 2006; 31:587-97.
28. Truong HT, Cottriall CL, McBrien NA. Expression of muscarinic receptors in tree shrew ocular tissues. Mol Vis 2009; 15:464-75.
29. Liu Q, Wu J, Wang X, Zeng J. Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs. Mol Vis 2007; 13:1234-44.
30. Barathi VA, Weon SR, Kam JH, Wess J, Beuerman RW. (2007) Experimental myopia in muscarinic receptor knockout mice: role of specific muscarinic receptor subtypes. ARVO Annual Meeting; 2007 May 6-10; Fort Lauderdale (FL).
31. Liu S, Li J, Tan DT, Beuerman RW. The eyelid margin: a transitional zone for 2 epithelial phenotypes. Arch Ophthalmol 2007; 125:523-32.
32. Brink N, Szamel M, Young AR, Wittern KP, Bergemann J. Comparative quantification of IL-10, IL-10, IL-10., TNFa and IL-7 mRNA levels in UV-irradiated human skin in vivo. Inflamm Res 2000; 49:290-6.
33. Wu YR. DNA, collagen, and uronic acid in form deprivation myopia. Invest Ophthalmol Vis Sci 1990; 31:254.
34. Rohrer B, Stell WK. Basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF-beta) act as stop and go signals to modulate postnatal ocular growth in the chick. Exp Eye Res 1994; 58:553-61.
35. Tong L, Huang XL, Koh AL, Zhang X, Tan DT, Chua WH. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology 2009; 116:572-9.
36. Ehlert FJ, Ostrom RS, Sawyer GW. Subtypes of the muscarinic receptor in smooth muscle. Life Sci 1997; 61:1729-40.
37. Matthiesen S, Bahulayan A, Holz O, Racke K. MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation. Life Sci 2007; 80:2259-62.
38. Shepard AR, Rae JL. Ion transporters and receptors in cDNA libraries from lens and cornea epithelia. Curr Eye Res 1998; 17:708-19.
39. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine-receptor proteins in brain with subtype specific antibodies. J Neurosci 1991; 11:3218-26.
40. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996; 10:69-99.
41. Caulfield MP, Birdsall NJM. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50:279-90.
42. Volpicelli LA, Levey AI. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 2004; 145:59-66.
43. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 2006; 148:565-78.
44. Felder CC, Bymaster FP, Ward J, DeLapp N. Therapeutic opportunities for muscarinic receptors in the central nervous system. J Med Chem 2000; 43:4333-53.
45. Eglen RM, Choppin A, Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 2001; 22:409-14.
46. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 2004; 44:423-50.
47. Gimbel HV. The control of myopia with atropine. Can J Ophthalmol 1973; 8:527-32.
48. Lind GJ, Chew SJ, Marzani D, Wallman J. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci 1998; 39:2217-31.
49. Dartt DA. Regulation of lacrimal gland secretion by neurotransmitters and the EGF family of growth factors. Exp Eye Res 2001; 73:741-52.
50. Collison DJ, Coleman RA, James RS, Carey J, Duncan G. Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques. Invest Ophthalmol Vis Sci 2000; 41:2633-41.
51. Wessler I, Kirkpatrick CJ, Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 1998; 77:59-79.
52. Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 2001; 91:1-34.
53. Hackel PO, Zwick E, Prenzel N, Ullrich A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 1999; 11:184-9.
54. Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS. Epidermal Growth Factor Receptor (EGFR) and EGFR Mutations, Function and Possible Role in Clinical Trials. Ann Oncol 1997; 8:1197-206.
55. Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res 2002; 21:555-76.
56. Kanno H, Horikawa Y, Hodges RR, Zoukhri D, Shatos MA, Rios JD, Dartt DA. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Am J Physiol Cell Physiol 2003; 284:C988-98.
57. Uchiyama T, Chess-Williams R. Muscarinic receptor subtypes of the bladder and gastrointestinal tract. J Smooth Muscle Res 2004; 40:237-47.
58. Elnatan A, Mitchelson F. The interaction of McN-A- 343 with muscarine receptors in cardiac and smooth muscle. Biochem Pharmacol 1993; 46:993-1003.
59. Burstein ES, Spalding TA, Brann MR. Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins. Mol Pharmacol 1997; 51:312-9.
60. Yuryev A, Mulyukov Z, Kotelnikova E, Maslov S, Egorov S, Nikitin A, Daraselia N, Mazo I. Automatic pathway building in biological association networks. BMC Bioinformatics 2006; 7:171.
61. Diebold Y, Rios JD, Hodges RR, Rawe I, Dartt DA. Presence of nerves and their receptors in mouse and human conjunctival goblet cells. Invest Ophthalmol Vis Sci 2001; 42:2270-82.